When was Terapet founded?

Terapet was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is Terapet located?

Terapet is headquartered in Geneva, Switzerland.

Who is the current CEO of Terapet?

Christina Vallgren of Terapet. They have also founded 1 company.

How many employees does Terapet have?

As of Sep 30, 2026, the latest employee count at Terapet is 13.

Is Terapet a funded company?

Terapet is a funded company, having raised a total of $3.75M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 04, 2019.

When was the latest funding round of Terapet?

Terapet's latest funding was a $***** Grant (prize money) round on Mar 01, 2024, with participation from 1 investor.

Where does Terapet rank among its competitors?

Terapet ranks 4th amongst 16 active competitors, of which 7 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Leo Cancer Care, which secured $65M in Jul, 2026.

Who are the top competitors of Terapet?

Terapet's top competitors include Leo Cancer Care, Varian Medical Systems and P-Cure. Among them, Leo Cancer Care secured the most recent funding round in July, 2026.

Terapet - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of integrated imaging solutions for proton therapy and nuclear medicine. It develops innovative platform technology for imaging in nuclear medicine, advancing proton therapy and nuclear imaging. The company's products enable quality and new clinical nuclear imaging in patient diagnosis and treatment, aiming to become a leading choice for radiotherapy and precision medicine. Its mission is to use its platform technology to create integrated imaging solutions that improve proton therapy, nuclear imaging, and precision medicine.

Website: terapet.ch
Social
Email ID: *****@terapet.ch

Key Metrics

Founded Year

2019

Location

Geneva, Switzerland

Stage

Seed

Total Funding

$3.75M in 10 rounds

Latest Funding Round

Grant (prize money), Mar 01, 2024, $*****

Investors

Nina Capital & 11 more

Ranked

4^th among 16 active competitors

Employee Count

13 as on Sep 30, 2026

Similar Companies

Leo Cancer Care & 15 more

View Terapet's full profile

Terapet has raised a total funding of $3.75M over 10 rounds. Its first funding round was on Oct 04, 2019. Its latest funding round was a Grant (prize money) round on Mar 01, 2024 for $*****. 1 investor participated in its latest round. Terapet has 12 institutional investors.

Here is the list of recent funding rounds of Terapet:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 01, 2024	5912688	Grant (prize money)	1380862	3371779	7182395	7192492
Oct 13, 2023	9561774	Grant (prize money)	5842393	6723197	1348526	Innosuisse
Jun 22, 2023	7581653	Grant (prize money)	3052905	4940775	8452761	Innosuisse

Access funding benchmarks and valuations. Sign up today!

View details of Terapet's funding rounds and investors

The founders of Terapet are Marcus palm, Christina Vallgren and Raymond Miralbell. Christina Vallgren is the CEO of Terapet.

Here are the details of Terapet's key team members:

Marcus palm: Co-Founder & CTO of Terapet. They serve on the board of 1 company.
Contact Info: 1 email address
Christina Vallgren: Co-Founder & CEO of Terapet. They serve on the board of 1 company.
Contact Info: 1 email address
Raymond Miralbell: Co-Founder & CSO of Terapet.
Contact Info: 1 email address

Terapet's Board of Directors

Terapet's board has 5 active members. Marcus palm, Christina Vallgren and Rolf Lewensohn are part of team and Mark Plesko and Giovanni Leo are independent board members.

Here is the list of Terapet's board of directors:

Name	Type	Representing	Status	Duration
Marcus palm	Team	-	Current	-
Christina Vallgren	Team	-	Current	-
vljgsop	Team	-	Current	7y 3m
Mark Plesko	Independent board member	-	Current	-
qjcfkzh	Independent board member	-	Current	2y 4m

View details of Terapet's Founder profiles and Board Members

Terapet's employee count trend

Terapet has 13 employees as of Sep 26. Here is Terapet's employee count trend over the years:

Uncover Terapet's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Terapet include Leo Cancer Care, Varian Medical Systems and P-Cure. Here is the list of Top 10 competitors of Terapet, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Leo Cancer Care 2014, Crawley (United Kingdom), Series D	Manufacturer of upright patient positioning systems for radiation therapy treatments	$130M	WARF, Catalio Capital Management & 13 others	61/100
2nd	Varian Medical Systems 1948, Palo Alto (United States), Acquired	Provider and manufacturer of radiotherapy software and hardware solutions for professionals	-	Accelmed, BB Biotech Ventures & 2 others	56/100
3rd	P-Cure 2007, Lod (Israel), Series B	Imaging-based proton radiation therapy for cancer treatment	$30M	-	53/100
4th	Terapet 2019, Geneva (Switzerland), Seed	Developer of integrated imaging solutions for proton therapy and nuclear medicine	$3.75M	Eureka, Nina Capital & 10 others	53/100
5th	B dot Medical 2017, Edogawa City (Japan), Series B	Developer of proton beam therapeutic devices for the treatment of cancer	$22M	Pegasus Tech Ventures, Mitsubishi UFJ Capital ... & 2 others	47/100
6th	Advanced Oncotherapy 1994, London (United Kingdom), Public	Provider of proton beam therapy system for the treatment of cancer	-	DNCA Finance, Aktiebolaget Segulah & 1 others	43/100
7th	HIL Medical 2010, Jerusalem (Israel), Series C	Developer of proton-beam radiotherapy device to treat solid tumors	$3.15M	EIC Fund, Europa & 3 others	38/100
8th	Provision Healthcare 2005, Knoxville (United States), Series B	Innovating cancer care with advanced proton therapy solutions and patient-centric approach	$30.4M	-	36/100
9th	Shanghai Aipqiang Particle Equipment 2012, Shanghai (China), Series A	Provider of proton therapy systems and related particle equipment	$6.29M	United Imaging Healthcare	32/100
10th	Proton Therapy Partners 2018, Wayne (United States), Funding Raised	Developer of proton therapy for treating cancer	-	Concord Health Partners	26/100